Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2025 Filed Feb 19, 2025 19:40 UTC |
Steel Bruce D.Director · President and CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 245,000 | Not disclosed Strike: $0.79 | Not disclosed |
DisclosureSEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 9 Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,000 Underlying: Common Stock · 245,000 shares Expires 2031-01-03 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 19:40 UTC |
Steel Bruce D.Director · President and CEO · 10% owner
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 100,110 | Not disclosed Strike: $3.53 | Not disclosed |
DisclosureSEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 8 Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,110 shares Expires 2030-05-27 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 19:40 UTC |
Steel Bruce D.Director · President and CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,110 | Not disclosed Strike: $0.79 | Not disclosed |
DisclosureSEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 7 Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,110 Underlying: Common Stock · 100,110 shares Expires 2030-05-27 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 19:40 UTC |
Steel Bruce D.Director · President and CEO · 10% owner
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 60,000 | Not disclosed Strike: $2.80 | Not disclosed |
DisclosureSEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 6 Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2030-05-18 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 19:40 UTC |
Steel Bruce D.Director · President and CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 60,000 | Not disclosed Strike: $0.79 | Not disclosed |
DisclosureSEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 5 Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2030-05-18 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 19:40 UTC |
Steel Bruce D.Director · President and CEO · 10% owner
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $4.75 | Not disclosed |
DisclosureSEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 4 Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2029-12-09 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 19:40 UTC |
Steel Bruce D.Director · President and CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $0.79 | Not disclosed |
DisclosureSEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 3 Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-12-09 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 19:40 UTC |
Steel Bruce D.Director · President and CEO · 10% owner
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 44,352 | Not disclosed Strike: $7.16 | Not disclosed |
DisclosureSEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 2 Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,352 shares Expires 2029-02-12 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 19:40 UTC |
Steel Bruce D.Director · President and CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 44,352 | Not disclosed Strike: $0.79 | Not disclosed |
DisclosureSEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 1 Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,352 Underlying: Common Stock · 44,352 shares Expires 2029-02-12 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 00:33 UTC |
Keyes Jason AChief Financial Officer
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 175,000 | Not disclosed Strike: $1.06 | Not disclosed |
DisclosureSEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 10 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 175,000 shares Expires 2033-01-02 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 00:33 UTC |
Keyes Jason AChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | Not disclosed Strike: $0.79 | Not disclosed |
DisclosureSEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 9 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2033-01-02 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 00:33 UTC |
Keyes Jason AChief Financial Officer
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 125,000 | Not disclosed Strike: $3.86 | Not disclosed |
DisclosureSEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 8 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2032-01-18 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 00:33 UTC |
Keyes Jason AChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | Not disclosed Strike: $0.79 | Not disclosed |
DisclosureSEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 7 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2032-01-18 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 00:33 UTC |
Keyes Jason AChief Financial Officer
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $5.03 | Not disclosed |
DisclosureSEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 6 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2031-01-03 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 00:33 UTC |
Keyes Jason AChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $0.79 | Not disclosed |
DisclosureSEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 5 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-01-03 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 00:33 UTC |
Keyes Jason AChief Financial Officer
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 90,000 | Not disclosed Strike: $2.45 | Not disclosed |
DisclosureSEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 4 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,000 shares Expires 2029-12-09 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 00:33 UTC |
Keyes Jason AChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 90,000 | Not disclosed Strike: $0.79 | Not disclosed |
DisclosureSEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 3 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2029-12-09 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 00:33 UTC |
Keyes Jason AChief Financial Officer
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 70,000 | Not disclosed Strike: $2.45 | Not disclosed |
DisclosureSEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 2 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,000 shares Expires 2029-02-12 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 00:33 UTC |
Keyes Jason AChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 70,000 | Not disclosed Strike: $0.79 | Not disclosed |
DisclosureSEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 1 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2029-02-12 F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| January 23, 2025 Filed Jan 24, 2025 23:37 UTC |
Keyes Jason AChief Financial Officer
|
SaleCommon Stock | 10,000 | $0.65 | $6,500.00 |
DisclosureSEC source: 0001415889-25-002070 · form4-01242025_110117.xml · nonDerivative · entry 1 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Keyes Trust Dated September 10, 2004 Disclosed balance after: 37,720 F1 · kind: The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.62 to $0.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 23:26 UTC |
Tom PennyPrincipal Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001415889-25-000858 · form4-01062025_110145.xml · derivative · entry 1 Tom Penny · CIK 0002012180 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2035-01-01 F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 23:09 UTC |
Zedelmayer ChristineSr. Vice President and COO
|
GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001415889-25-000841 · form4-01062025_110148.xml · derivative · entry 1 Zedelmayer Christine · CIK 0001797818 · Sr. Vice President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2035-01-01 F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 23:06 UTC |
Connelly StephenDirector · Chief Scientific Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001415889-25-000838 · form4-01062025_110104.xml · derivative · entry 1 Connelly Stephen · CIK 0001746808 · Director · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2035-01-01 F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 23:21 UTC |
BRADBURY DANIELDirector · EXECUTIVE CHAIRMAN · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001415889-25-000852 · form4-01062025_110151.xml · derivative · entry 1 BRADBURY DANIEL · CIK 0001236397 · Director · EXECUTIVE CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-01-01 F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 18:24 UTC |
Steel Bruce D.Director · President and CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 410,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001415889-25-000856 · form4-01062025_110153.xml · derivative · entry 1 Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2035-01-01 F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 23:11 UTC |
Keyes Jason AChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001415889-25-000843 · form4-01062025_110147.xml · derivative · entry 3 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2035-01-01 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| December 11, 2024 Filed Dec 12, 2024 22:45 UTC |
Colabuono PeterDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001415889-24-029164 · form4-12122024_101224.xml · derivative · entry 1 Colabuono Peter · CIK 0001819620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2034-12-10 F1 · derivative.exercise_date: The option vests in 36 equal monthly installments following the grant date of December 11, 2024. Read SEC document |
| December 10, 2024 Filed Jan 6, 2025 23:11 UTC |
Keyes Jason AChief Financial Officer
|
GrantCommon Stock | 15,000 | $0.54 | $8,100.00 |
DisclosureSEC source: 0001415889-25-000843 · form4-01062025_110147.xml · nonDerivative · entry 1 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,913 F1 · kind: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 23:23 UTC |
Keyes Jason AChief Financial Officer
|
SaleCommon Stock | 10,000 | $0.70 | $7,000.00 |
DisclosureSEC source: 0001415889-24-026987 · form4-11152024_111115.xml · nonDerivative · entry 1 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Keyes Trust Dated September 10, 2004 Disclosed balance after: 47,720 F1 · kind: The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.67 to $0.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 28, 2024 Filed Oct 29, 2024 20:15 UTC |
Tom PennyPrincipal Accounting Officer
|
SaleCommon Stock | 2,835 | $1.25 | $3,543.75 |
DisclosureSEC source: 0001415889-24-025695 · form4-10292024_041001.xml · nonDerivative · entry 2 Tom Penny · CIK 0002012180 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,533 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2024. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 00:59 UTC |
Zedelmayer ChristineSr. Vice President and COO
|
SaleCommon Stock | 15,000 | $1.25 | $18,750.00 |
DisclosureSEC source: 0001415889-24-025804 · form4-10312024_121034.xml · nonDerivative · entry 1 Zedelmayer Christine · CIK 0001797818 · Sr. Vice President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,246 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 19, 2024. F2 · balance_after: Includes 15,000 shares acquired by the reporting person on June 10, 2024 under the Issuer's 2018 Employee Stock Purchase Plan. Read SEC document |
| October 25, 2024 Filed Oct 29, 2024 20:15 UTC |
Tom PennyPrincipal Accounting Officer
|
SaleCommon Stock | 683 | $1.25 | $853.75 |
DisclosureSEC source: 0001415889-24-025695 · form4-10292024_041001.xml · nonDerivative · entry 1 Tom Penny · CIK 0002012180 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,368 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2024. Read SEC document |
| September 26, 2024 Filed Sep 27, 2024 23:38 UTC |
Keyes Jason AChief Financial Officer
|
SaleCommon Stock | 10,000 | $0.81 | $8,100.00 |
DisclosureSEC source: 0001415889-24-024079 · form4-09272024_110919.xml · nonDerivative · entry 1 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Keyes Trust Dated September 10, 2004 Disclosed balance after: 57,720 F1 · kind: The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.79 to $0.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 22:14 UTC |
Tom PennyPrincipal Accounting Officer
|
SaleCommon Stock | 38,806 | $0.85 | $32,985.10 |
DisclosureSEC source: 0001415889-24-023546 · form4-09172024_100911.xml · nonDerivative · entry 1 Tom Penny · CIK 0002012180 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,051 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.83 to $0.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Includes 15,000 shares acquired by the reporting person under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024. Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 21:52 UTC |
Keyes Jason AChief Financial Officer
|
SaleCommon Stock | 10,000 | $0.87 | $8,700.00 |
DisclosureSEC source: 0001415889-24-019776 · form4-07182024_090731.xml · nonDerivative · entry 1 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Keyes Trust Dated September 10, 2004 Disclosed balance after: 67,720 F1 · kind: The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.9342, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 22, 2024 Filed May 23, 2024 18:00 UTC |
MANIAN BALA SDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001415889-24-014369 · form4-05232024_100515.xml · derivative · entry 1 MANIAN BALA S · CIK 0000941871 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date. Read SEC document |
| May 22, 2024 Filed May 23, 2024 21:54 UTC |
Troupin BarbaraDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001415889-24-014358 · form4-05232024_090501.xml · derivative · entry 1 Troupin Barbara · CIK 0001627886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date. Read SEC document |
| May 22, 2024 Filed May 23, 2024 22:04 UTC |
DEMSKI MARTHA JDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001415889-24-014372 · form4-05232024_100518.xml · derivative · entry 1 DEMSKI MARTHA J · CIK 0001198230 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date. Read SEC document |
| May 22, 2024 Filed May 23, 2024 22:02 UTC |
Pruzanski MarkDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001415889-24-014370 · form4-05232024_100533.xml · derivative · entry 1 Pruzanski Mark · CIK 0001559569 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date. Read SEC document |
| May 22, 2024 Filed May 23, 2024 21:59 UTC |
McDermott Charles DouglasDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001415889-24-014367 · form4-05232024_090548.xml · derivative · entry 1 McDermott Charles Douglas · CIK 0001710696 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date. Read SEC document |
| May 22, 2024 Filed May 23, 2024 21:56 UTC |
Xu Yu (Katherine)Director
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001415889-24-014364 · form4-05232024_090523.xml · derivative · entry 1 Xu Yu (Katherine) · CIK 0001843348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 23:12 UTC |
Zedelmayer ChristineSr. Vice President and COO
|
GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001209191-24-000516 · doc4.xml · derivative · entry 3 Zedelmayer Christine · CIK 0001797818 · Sr. Vice President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 23:17 UTC |
Connelly StephenDirector · Chief Scientific Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001209191-24-000523 · doc4.xml · derivative · entry 1 Connelly Stephen · CIK 0001746808 · Director · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2034-01-01 F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 23:20 UTC |
BRADBURY DANIELDirector · Executive Chairman · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001209191-24-000532 · doc4.xml · derivative · entry 1 BRADBURY DANIEL · CIK 0001236397 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-01-01 F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 18:19 UTC |
Steel Bruce D.Director · President and CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 410,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001209191-24-000529 · doc4.xml · derivative · entry 1 Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2034-01-01 F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 23:10 UTC |
Keyes Jason AChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001209191-24-000515 · doc4.xml · derivative · entry 4 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 23:14 UTC |
Rothman JoelChief Development Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001209191-24-000518 · doc4.xml · derivative · entry 3 Rothman Joel · CIK 0001842921 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| December 08, 2023 Filed Jan 3, 2024 23:12 UTC |
Zedelmayer ChristineSr. Vice President and COO
|
GrantCommon Stock | 8,804 | $0.58 | $5,106.32 |
DisclosureSEC source: 0001209191-24-000516 · doc4.xml · nonDerivative · entry 2 Zedelmayer Christine · CIK 0001797818 · Sr. Vice President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,246 F1 · kind: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 08, 2023 Filed Jan 3, 2024 23:10 UTC |
Keyes Jason AChief Financial Officer
|
GrantCommon Stock | 8,805 | $0.58 | $5,106.90 |
DisclosureSEC source: 0001209191-24-000515 · doc4.xml · nonDerivative · entry 2 Keyes Jason A · CIK 0001678152 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,913 F1 · kind: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 08, 2023 Filed Jan 3, 2024 23:14 UTC |
Rothman JoelChief Development Officer
|
GrantCommon Stock | 8,804 | $0.58 | $5,106.32 |
DisclosureSEC source: 0001209191-24-000518 · doc4.xml · nonDerivative · entry 2 Rothman Joel · CIK 0001842921 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,150 F1 · kind: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.